Navigation Links
Fipronil and imidacloprid reduce honeybee mitochondrial activity
Date:8/6/2014

PENSACOLA, Fla. New research published in Environmental Toxicology and Chemistry addresses the effects of two broad-spectrum systemic insecticides, fipornil and imidacloprid, on honeybees. These insecticides are widely used in agriculture, and the authors conclude that fipronil and imidacloprid are inhibitors of mitochondrial bioenergetics, resulting in depleted cell energy. This action can explain the toxicity of these compounds for honeybees.

Scientists are urgently trying to determine the causes of colony collapse disorder and the alarming population declines of honeybees. The cross-pollination services they provide are required by approximately 80 percent of all flowering plants, and 1/3 of all agricultural food production directly depends on bee pollination. As a result, there has been a flurry of research on honeybee parasitic mite infestations, viral diseases, and the direct and indirect impacts of pesticides.

The effects of pyrazoles (e.g., fipronil) and neonicotinoids (e.g., imidacloprid) on the nervous system are fairly well documented. Daniel Nicodemo, professor of ecology and beekeeping at the Universidade Estadual Paulista in Dracena, Brazil, and lead author of the study states, "These insecticides affect the nervous system of pest and beneficial insects, often killing them. Sublethal effects related to insect behavior have been described in other studies; even a few nanograms of active ingredient disturbed the sense of taste, olfactory learning and motor activity of the bees." A key characteristic of colony collapse disorder is the incapacity of the honeybees to return to their hives, and these disruptions have a direct impact on that ability.

In this study, Nicodemo et al. looked at the effects of fipronil and imidacloprid on the bioenergetics functioning of mitochondria isolated from the heads and thoraces of Africanized honeybees. Mitochondria are the power plants of a cell, generating most of a cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy.

Honeybee flight muscles are strongly dependent on high levels of oxygen consumption and energy metabolism. Mitochondrial oxidative phosphorylation drives ATP synthesis, which is required to contract the muscles during flight. "If something goes wrong, the energy production is impaired," explains Nicodemo. "Similar to a plane, honeybees require clean fuel in order to fly." Both fipronil and imidacloprid negatively affected the mitochondrial bioenergetics of the head and thorax of the honeybees. While at sublethal levels, insecticide damage may not be evident, even such low level exposure clearly contributes to the inability of a honeybee to forage and return to the hive, which could result in declining bee populations.


'/>"/>

Contact: Jennifer Lynch
jen.lynch@setac.org
850-469-1500 x109
Society of Environmental Toxicology and Chemistry
Source:Eurekalert

Related medicine news :

1. Production and Market of Imidacloprid in China
2. Community pharmacist intervention boosts drug adherence, reduces health-care costs
3. Diet change -- A solution to reduce water use?
4. 5 Tips for Back-to-School: What You Need to Know to Reduce Stress and Plan for a Healthy Transition from Nina Radcliff, MD
5. Eating resistant starch may help reduce red meat-related colorectal cancer risk
6. Algorithm reduces use of CT scans when diagnosing children with appendicitis
7. Cataract Surgery: New Technology for Reduced Dependence on Glasses
8. New Standing Desk Anti-fatigue Mats from Martinson-Nicholls Reduce Leg Fatigue and Discomfort Working at Standing and Sit-to-Stand Desks
9. Surgical safety program greatly reduces surgical site infections for heart operations
10. Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening
11. Seeing the same GP at every visit will reduce emergency department attendance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology: